These findings support the roles of these two lipid-binding chaperones in the pathogenesis of vascular complications of diabetes, and provide possible perspective for using lipocalin-2 and RBP4 as biomarkers for early detection of high-risk individuals developing cardiovascular diseases and potential therapeutic targets for atherosclerosis. Here, LCN2 is linked to diabetes mellitus.